| 000 | 01603 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515135630.0 | ||
| 264 | 0 | _c20090717 | |
| 008 | 200907s 0 0 eng d | ||
| 022 | _a0049-3848 | ||
| 024 | 7 |
_a10.1016/j.thromres.2008.07.018 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTsangaris, Iraklis | |
| 245 | 0 | 0 |
_aThe impact of the PAI-1 4G/5G polymorphism on the outcome of patients with ALI/ARDS. _h[electronic resource] |
| 260 |
_bThrombosis research _cApr 2009 |
||
| 300 |
_a832-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAcute Lung Injury _xgenetics |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 |
_aBronchoalveolar Lavage Fluid _xchemistry |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHomozygote |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aINDEL Mutation |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPlasminogen Activator Inhibitor 1 _xblood |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRespiration, Artificial |
| 650 | 0 | 4 |
_aRespiratory Distress Syndrome _xgenetics |
| 700 | 1 | _aTsantes, Argiris | |
| 700 | 1 | _aBonovas, Stefanos | |
| 700 | 1 | _aLignos, Michalis | |
| 700 | 1 | _aKopterides, Petros | |
| 700 | 1 | _aGialeraki, Argiro | |
| 700 | 1 | _aRapti, Evdoxia | |
| 700 | 1 | _aOrfanos, Stylianos | |
| 700 | 1 | _aDimopoulou, Ioanna | |
| 700 | 1 | _aTravlou, Anthi | |
| 700 | 1 | _aArmaganidis, Apostolos | |
| 773 | 0 |
_tThrombosis research _gvol. 123 _gno. 6 _gp. 832-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.thromres.2008.07.018 _zAvailable from publisher's website |
| 999 |
_c18272572 _d18272572 |
||